Johns Hopkins Diabetes Guide
Naltrexone/Buproprion
Naltrexone/Buproprion is a topic covered in the Johns Hopkins Diabetes Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Naltrexone/bupropion was approved as an adjunct to diet and exercise in adults with BMI ≥30 kg/m2 or ≥27 kg/m2 with one or more weight-related comorbidities to achieve weight loss.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Naltrexone/bupropion was approved as an adjunct to diet and exercise in adults with BMI ≥30 kg/m2 or ≥27 kg/m2 with one or more weight-related comorbidities to achieve weight loss.
There's more to see -- the rest of this entry is available only to subscribers.
Last updated: August 22, 2017
Citation
Lee, Clare, and Brian Pinto. "Naltrexone/Buproprion." Johns Hopkins Diabetes Guide, 2017. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547197/all/Naltrexone_Buproprion.
Lee C, Pinto B. Naltrexone/Buproprion. Johns Hopkins Diabetes Guide. 2017. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547197/all/Naltrexone_Buproprion. Accessed January 24, 2021.
Lee, C., & Pinto, B. (2017). Naltrexone/Buproprion. In Johns Hopkins Diabetes Guide Retrieved January 24, 2021, from https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547197/all/Naltrexone_Buproprion
Lee C, Pinto B. Naltrexone/Buproprion [Internet]. In: Johns Hopkins Diabetes Guide. ; 2017. [cited 2021 January 24]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547197/all/Naltrexone_Buproprion.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Naltrexone/Buproprion
ID - 547197
A1 - Lee,Clare,M.D., MHS
AU - Pinto,Brian,Pharm.D.
Y1 - 2017/08/22/
BT - Johns Hopkins Diabetes Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547197/all/Naltrexone_Buproprion
DB - Johns Hopkins Guide
DP - Unbound Medicine
ER -
